Indeed, we have recently reported that HMGA1 protects pancreatic adenocarcinoma cells from gemcitibine-induced apoptosis and in this context is a potential molecular determinant of chemoresistance in pancreatic cancer (Liau et al, 2006). The gene discussed is HMGA1; the disease is pancreatic adenocarcinoma.